Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer

NCT02254278 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

316

Enrollment

OTHER

Sponsor class

Conditions

Stage III Oropharyngeal Squamous Cell Carcinoma
Stage IVA Oropharyngeal Squamous Cell Carcinoma
Stage IVB Oropharyngeal Squamous Cell Carcinoma
Stage IVC Oropharyngeal Squamous Cell Carcinoma
Tongue Carcinoma

Interventions

DRUG: Cisplatin
RADIATION: IMRT 6 weeks
RADIATION: IMRT 5 weeks

Sponsor

NRG Oncology

Collaborators

[object Object]